Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study.

@article{Schmid2016IntralymphaticII,
  title={Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study.},
  author={Johannes Martin Schmid and Homaira Nezam and Hans Henrik Torp Madsen and Alexander C Schmitz and H J Hoffmann},
  journal={Clinical and translational allergy},
  year={2016},
  volume={6},
  pages={
          19
        }
}
BACKGROUND Allergen Immunotherapy is a promising treatment of allergy. Seven patients with rhinoconjunctivitis to grass allergen were treated with intralymphatic immunotherapy (ILIT) to explore whether this treatment could be performed. Effect of treatment was assessed as change in symptom medication score, response in skin prick test and nasal allergen provocation. ILIT deposits allergen in an inguinal lymph node to elicit a strong immune stimulus. This allowed us to monitor appearance of… CONTINUE READING
Tweets
This paper has been referenced on Twitter 17 times. VIEW TWEETS